MANE
Veradermics, Inc · Healthcare · Market cap $4.3B
Insiders sold $103.1M net in the last 90 days ·4 sellers, 0 buyers· latest Form 4 filed Aug 21, 2026
Insider Buying
$53.1M
reported purchases (SEC code P)
Insider Selling
$103.1M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Latest filing
Sep 3, 2026
MONTANOVA CAPITAL, LLC
Veradermics, Inc (MANE) has 14 SEC Form 4 filings (64 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Sep 3, 2026.
Inside the rolling window, 8 insiders at Veradermics, Inc reported 7 open-market purchases totaling $53.1M and 4 open-market sales totaling $103.1M. The most active filer is Director, 10% Owner SUVRETTA CAPITAL MANAGEMENT, LLC with 3 filings. Insiders have net sold $103.1M over the trailing 6 months. The most recent open-market filing is a sale of 750,000 shares by Director MONTANOVA CAPITAL, LLC, dated Aug 19, 2026, worth $80.4M.
- Industry:Biotechnology
- CEO:Reid Waldman
- Employees:21
- HQ:New Haven, CT, US
- IPO:2026-02-04
| Source | |||||||
|---|---|---|---|---|---|---|---|
MONTANOVA CAPITAL, LLCFirst filing | Director | Sale | 750,000 | $80.4M | Aug 21 | +1.0% | SEC ↗ |
Durso Timothy AugustFirst filing | Chief Technical Officer | Sale | 43,500 | $4.7M | Aug 19 | -6.6% | SEC ↗ |
Waldman Reid AlexanderFirst filing | Chief Executive Officer | Sale | 67,500 | $7.3M | Aug 19 | -6.6% | SEC ↗ |
CHILDS JOHN WFirst in 5 months | Director | Sale | 100,000 | $10.7M | Aug 14 | — | SEC ↗ |
| Director | Purchase | 294,117 | $5.0M | Feb 27 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 155,953 | $5.8M | Feb 9 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 96,200 | $3.7M | Feb 9 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 30,521 | $1.1M | Feb 9 | — | SEC ↗ | |
| Director | Purchase | 58,823 | $1000K | Feb 5 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 1,075,000 | $18.3M | Feb 5 | — | SEC ↗ | |
Longitude Capital Partners V, LLCFirst filing | 10% Owner | Purchase | 1,075,000 | $18.3M | Feb 5 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does MANE have?
Veradermics, Inc (MANE) has 14 SEC Form 4 filings (64 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Sep 3, 2026.
When was the most recent SEC Form 4 filing for MANE?
The most recent Form 4 filing for MANE on Tracefour is dated Sep 3, 2026.
Who is the most active insider at MANE?
The most active SEC Form 4 filer at MANE in the rolling window is Director, 10% Owner SUVRETTA CAPITAL MANAGEMENT, LLC, with 3 filings.
What is the net insider flow at MANE over the last 6 months?
Over the trailing 180 days, insiders at MANE have net sold $103.1M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at MANE in the current window?
Inside the rolling window, insiders at MANE bought $53.1M and sold $103.1M based on SEC Form 4 filings.
Can I get alerts for MANE insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Veradermics, Inc (MANE). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Veradermics, Inc is in the Healthcare sector.